Announcements Trials
Browse Landscape

Phase

Phase 1 11Phase 2 5Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 16Glioma 14Neoplasms 13Breast Neoplasms 13Prostatic Neoplasms 12Brain Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Multiple Myeloma 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Recurrence 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Skin Neoplasms 4Lymphoma 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Lung Neoplasms 3Colonic Neoplasms 3Astrocytoma 3

Interventions

Utrogestan 1Progestins 1Progesterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Gliosarcoma × 90 days × Clear all
NCT05091866 2026-05-05

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Emory University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡